VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for patent application No. 3243445 entitled, “Contact-Free Breath Analysis Device and Method” to the Company. Recently the U.S. Patent and Trademark Office issued a notice of allowance for the same patent application filed in the United Sta ...

Core Points - Cannabix Technologies Inc. has received a notice of allowance for its patent application regarding a "Contact-Free Breath Analysis Device and Method" from the United States Patent and Trademark Office [1][3] - The technology involves dual mode contactless and traditional mouthpiece breath capture and analysis, applicable in various environments such as vehicles and workplaces, enabling fast and reliable testing without physical contact [2][3] - This patent application enhances Cannabix's position in breath sampling and detection techniques, contributing to its intellectual property portfolio [3] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing technologies for workplaces and law enforcement, focusing on recent marijuana use detection [4] - The company has developed the BreathLogix autonomous alcohol screening device aimed at improving alcohol safety and monitoring in organizations [4]